Skip to main content
TipRanks
Go Ultimate75% OFF

Baker Biotech Capital , Llc Insider Profile

4 Followers

Baker Biotech Capital , Llc, Ten Percent Owner at Heron Therapeutics, holds 342.04K shares in Ocera Therapeutics (Ticker: OCRX), holds 1.48M shares in Genomic Health (Ticker: GHDX), holds 1.59M shares in XOMA Royalty Corporation (Ticker: XOMA). Most recently, Baker Biotech Capital , Llc Bought ― shares of Ocera Therapeutics on Mar 14, 2012 for an estimated value of $311.46K.

Baker Biotech Capital , Llc's Trading History

OCRX
Ocera Therapeutics
Mar 14, 2012―Informative Buy311.46K$612.25K
GHDX
Genomic Health
Mar 09, 2012―Informative Buy135.71K$94.21M
XOMA
XOMA Royalty Corporation
Mar 08, 2012―Informative Buy―$63.69M
PCYC
Pharmacyclics
Feb 14, 2012―Informative Buy3.13M―
GEVA
Synageva
Jan 09, 2012―Uninformative Buy4.72M―
SGEN
Seagen
Jan 04, 2012―Informative Buy2.12M$1.14B
AUXL
Auxilium
Aug 03, 2011―Informative Sell1.95M―
INCY
Incyte
Sep 23, 2010Director, Ten Percent OwnerInformative Sell5.91M$352.75M
HRTX
Heron Therapeutics
Oct 27, 2009Ten Percent OwnerInformative Buy―$406.88K
BCRX
BioCryst
Jun 01, 2009Ten Percent OwnerInformative Sell997.42K$11.34M
VPHM
Viropharma
May 08, 2009―Informative Buy――
ACGN
Aceragen
―――$79.46K

You May Also Like

Baker Biotech Capital , Llc insider profile FAQ

What is the percentage of profitable transactions made by Baker Biotech Capital , Llc?
The percentage of profitable transactions made by Baker Biotech Capital , Llc is 58%.
What is the average return per transaction made by Baker Biotech Capital , Llc?
The average return per transaction made by Baker Biotech Capital , Llc is 112.50%.
What stocks does Baker Biotech Capital , Llc hold?
Baker Biotech Capital , Llc holds: HRTX, INCY, SGEN, GHDX, BCRX, XOMA, OCRX, ACGN, AUXL, PCYC, GEVA, VPHM stocks.
What was Baker Biotech Capital , Llc’s latest transaction?
Baker Biotech Capital , Llc’s latest transaction was an Informative Buy of $311.46K.
What was Baker Biotech Capital , Llc's most profitable transaction?
Baker Biotech Capital , Llc’s most profitable transaction was an Informative Buy of PCYC stock on August 24, 2011. The return on the trade was 524.90%.
What is Baker Biotech Capital , Llc's role in Heron Therapeutics?
Baker Biotech Capital , Llc's role in Heron Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.